abciximab Injection

Brand(s)
ReoPro
Category(s)
prescription
SPL Type(s)
Human Prescription
Master SPL
Eli Lilly And Company (2013-12-04)
Oldest Current Product
1993-12-16
License(s)
BLA
RxNORM
INJECTION\ABCIXIMAB
SPL Active
INTRAVENOUS\INJECTION, SOLUTION\ABCIXIMAB
SPL Moiety
INTRAVENOUS\INJECTION, SOLUTION\ABCIXIMAB

product(s) by strength(s)

5 ml abciximab 2 mg/ml injection

original product(s)(s)

#idbrandcategorylabelerfirst marketedactive ingredient(s)routedose formapplicationspl
1000027140ReoProBLAEli Lilly And Company1993-12-16ABCIXIMABINTRAVENOUSINJECTION, SOLUTION103575033d4c3b-4630-4256-b8f7-9ed5f15de9a3

application(s)

#idtitleapprovedtradenamesfda division
1103575abciximab Application1994-12-22ReoProCDER

spl(s)

#idtitlecategorytypelabelerlabeler actlast updateversionproduct(s)
1033d4c3b-4630-4256-b8f7-9ed5f15de9a3 (view SPL)ReoPro AbciximabprescriptionHuman PrescriptionEli Lilly And CompanyAPI MANUFACTURE, MANUFACTURE2013-12-044000027140

Data from: FDAOB, FDAPB, LOINC, MTHSPL, NDFRT, NCIT, RxNORM, UNII